Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

U.S. patent issues for GenVec's advanced gene therapy vectors

April 3, 1998

TAPET efficacy reported at AACR meeting

April 2, 1998

Novel liposomal delivery system available for licensing from NCI/NIH

April 2, 1998

NIH offers gene expression detection technology for licensing

March 30, 1998

Demeter granted U.S. patent for peptide stabilization

March 30, 1998

PIN*POINT method available for licensing from NIH

March 27, 1998

Incyte licenses RNA amplification technology and related patent

March 27, 1998

FDA advisory committee recommends expanded labeling for CEPRATE SC System

March 26, 1998

Ribozyme, Parke-Davis collaboration confirmed

March 25, 1998

Progenitor, CAT establish gene-to-clinic collaboration

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...